tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:VX1 Stock Latest News

Vertex Pharmaceuticals, WuXi Biologics enter license and research service pact
The FlyVertex Pharmaceuticals, WuXi Biologics enter license and research service pact
5d ago
VRTX
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Positive Risk-Reward on Emerging Renal Pipeline and Pove IgAN Phase 3 Catalyst Supports Buy Rating
8d ago
VRTX
Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays
PremiumThe Fly
Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays
11d ago
VRTX
Vertex Pharmaceuticals price target raised to $545 from $535 at UBS
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $545 from $535 at UBS
12d ago
VRTX
Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI
15d ago
VRTX
Vertex Pharmaceuticals gets orphan status for membranous nephropathy treatment
PremiumThe FlyVertex Pharmaceuticals gets orphan status for membranous nephropathy treatment
16d ago
VRTX
Vertex upgraded to Outperform from Sector Perform at RBC Capital
Premium
The Fly
Vertex upgraded to Outperform from Sector Perform at RBC Capital
17d ago
VRTX
Maze Therapeutics price target raised to $46 from $37 at BTIG
Premium
The Fly
Maze Therapeutics price target raised to $46 from $37 at BTIG
19d ago
MAZE
VRTX
Bernstein upgrades Vertex, names top 2026 biotech pick
PremiumThe Fly
Bernstein upgrades Vertex, names top 2026 biotech pick
26d ago
VRTX
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
27d ago
VRTX
Sionna Therapeutics price target raised to $58 from $50 at BTIG
PremiumThe Fly
Sionna Therapeutics price target raised to $58 from $50 at BTIG
1M ago
SION
VRTX
Vertex Pharmaceuticals assumed with a Buy at UBS
PremiumThe Fly
Vertex Pharmaceuticals assumed with a Buy at UBS
1M ago
VRTX
Wolfe upgrades Vertex Pharmaceuticals, says ‘may be due for a rebound’
PremiumThe FlyWolfe upgrades Vertex Pharmaceuticals, says ‘may be due for a rebound’
1M ago
VERA
VRTX
Vertex Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
Vertex Pharmaceuticals upgraded to Outperform from Peer Perform at Wolfe Research
1M ago
VRTX
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
1M ago
BA
CI
BofA lays out Top 10 U.S. ideas for Q1
PremiumThe Fly
BofA lays out Top 10 U.S. ideas for Q1
1M ago
BA
CI
Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink
1M ago
VRTX
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
PremiumRatings
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside
2M ago
VRTX
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strong Market Position and Promising Growth Potential Justify Buy Rating
2M ago
VRTX
Vertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
PremiumRatingsVertex Pharmaceuticals: Promising Advancements in Kidney Disease Treatments Drive Buy Rating
2M ago
VRTX
Vertex Pharmaceuticals presents new data on CASGEVY at ASH
Premium
The Fly
Vertex Pharmaceuticals presents new data on CASGEVY at ASH
2M ago
VRTX
Vertex Pharmaceuticals price target raised to $564 from $516 at Morgan Stanley
Premium
The Fly
Vertex Pharmaceuticals price target raised to $564 from $516 at Morgan Stanley
2M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >